First Time Loading...

ChemoCentryx Inc
NASDAQ:CCXI

Watchlist Manager
ChemoCentryx Inc Logo
ChemoCentryx Inc
NASDAQ:CCXI
Watchlist
Price: 51.99 USD Market Closed
Updated: May 1, 2024
Section:
 

Wall Street
Price Targets

CCXI Price Targets Summary
ChemoCentryx Inc

There are no price targets for CCXI.
CCXI Lowest Forecast
Wall Street Target
Not Available
CCXI Average Forecast
Wall Street Target
Not Available
CCXI Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
ChemoCentryx Inc Competitors:
Price Targets
ADMA
ADMA Biologics Inc
31% Upside
MNKD
MannKind Corp
76% Upside
IPSC
Century Therapeutics Inc
420% Upside
ASND
Ascendis Pharma A/S
33% Upside
ADMA
ADMA Biologics Inc
31% Upside
MNKD
MannKind Corp
76% Upside
IPSC
Century Therapeutics Inc
420% Upside
ASND
Ascendis Pharma A/S
33% Upside
VCYT
Veracyte Inc
61% Upside
KNTE
Kinnate Biopharma Inc
9% Downside
NIOX
Niox Group PLC
9% Upside
ICCC
ImmuCell Corp
185% Upside

Revenue
Forecast

Revenue Estimate
ChemoCentryx Inc

For the last 8 years the compound annual growth rate for ChemoCentryx Inc's revenue is 23%. The projected CAGR for the next 2 years is 139%.

23%
Past Growth
139%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
ChemoCentryx Inc

Operating Income forecast
is not available for
ChemoCentryx Inc

Net Income
Forecast

Net Income Estimate
ChemoCentryx Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss
What are analyst estimates?

See Also

Summary
CCXI intrinsic value, competitors valuation, and company profile.
DCF Valuation
CCXI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CCXI stock valuation using valuation multiples.
Wall Street Estimates
CCXI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CCXI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CCXI's stock price target?
Not Available

CCXI doesn't have any price targets made by Wall Street professionals.

What is ChemoCentryx Inc's Revenue forecast?
Projected CAGR
139%

For the last 8 years the compound annual growth rate for ChemoCentryx Inc's revenue is 23%. The projected CAGR for the next 2 years is 139%.

ALPHA SPREAD
Join more than 133,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.